STEPHEN ADAMS: Open Payments
NPI 1245363993 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$59,503 in 196 payments from 17 companies in 2025. Trend: 2023 $132,866 · 2024 $153,050 · 2025 $59,503
Speaker / faculty: $46,881Travel & lodging: $7,770Food & beverage: $4,851
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 85 | $46,617 |
| Gilead Sciences, Inc. | 51 | $11,532 |
| Vanda Pharmaceuticals Inc. | 7 | $210 |
| Otsuka America Pharmaceutical, Inc. | 11 | $201 |
| Teva Pharmaceuticals USA, Inc. | 10 | $138 |
| Neurocrine BioSciences, Inc. | 5 | $135 |
| Novo Nordisk Inc | 1 | $125 |
| Merck Sharp & Dohme LLC | 5 | $112 |
| EMD Serono, Inc. | 5 | $95 |
| Lundbeck LLC | 5 | $86 |
Products named: DOVATO, APRETUDE, Biktarvy, CABENUVA, HETLIOZ, REXULTI, INGREZZA, Wegovy.
Industry payments across MO — which companies pay providers there.
